Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Allergan Plc CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK DUBLIN L2 D17 E400 IRL

www.allergan.com P: 862-261-7000

Description:

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 63,503,972
Shares Outstanding, K 329,002
Annual Sales, $ 16,089 M
Annual Net Income, $ -5,271 M
Last Quarter Sales, $ 4,351 M
Last Quarter Net Income, $ -317,200 K
60-Month Beta 1.20
% of Insider Shareholders 0.08%
% of Institutional Shareholders 83.91%
Float, K 328,739
% Float 99.92%

Growth:

1-Year Return 37.82%
3-Year Return -16.40%
5-Year Return -34.92%
5-Year Revenue Growth 23.17%
5-Year Earnings Growth 26.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 5.22 on 02/10/20
Latest Earnings Date 05/07/20
Earnings Per Share ttm 17.64
EPS Growth vs. Prev Qtr 22.82%
EPS Growth vs. Prev Year 21.68%
Annual Dividend Rate, $ 2.96
Annual Dividend Yield 1.53%
Most Recent Dividend 0.740 on 04/15/20
Next Ex-Dividends Date 04/15/20
Dividend Payable Date 03/20/15
Dividend Payout Ratio 16.67%
Most Recent Split 2-1 on 10/30/97

AGN Ratios

Ratio
Price/Earnings ttm 10.94
Price/Earnings forward 11.56
Price/Earnings to Growth 1.63
Return-on-Equity % 8.46%
Return-on-Assets % 5.31%
Profit Margin % -32.76%
Debt/Equity 0.32
Price/Sales 3.95
Price/Cash Flow 5.26
Price/Book 1.09
Book Value/Share 177.28
Interest Coverage -5.54

AGN Dividends

Date Value
04/15/20 $0.7400
02/13/20 $0.7400
11/12/19 $0.7400
08/12/19 $0.7400
05/13/19 $0.7400
02/14/19 $0.7400
11/09/18 $0.7200
08/16/18 $0.7200
05/17/18 $0.7200
02/27/18 $0.7200
11/16/17 $0.7000
08/16/17 $0.7000
05/16/17 $0.7000
02/24/17 $0.7000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar